Solid IO, a pioneering medtech company specializing in patient-specific organ-on-chip technology, has successfully closed its first funding round, led by Nordic Science Investments and including funding from BSV Ventures, Helsinki University Funds and a private European investor. This investment accelerates the development of Solid IO’s tumor-on-chip platform, a breakthrough technology that enables real time, biologically relevant insights to guide personalized cancer treatment and immunotherapy advancements.

Read more >>